Application of collateral activating and pain relieving capsules as medicine for treating diabetic peripheral neuropathy
A technology for peripheral neuropathy and diabetes, applied in the field of medicine
Active Publication Date: 2016-12-14
HINYE PHARM CO LTD
View PDF3 Cites 1 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0007] Huoluo Xiaotong Capsules for the treatment of diabetic peripheral neuropathy has not been reported yet
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment
[0016] Example: Observation of clinical curative effect of Huoluo Xiaotong Capsules in treating diabetic peripheral neuropathy (cold-damp numbness combined with blood stasis syndrome).
[0017] 1. Clinical data and methods.
[0018] 1 Clinical data.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention relates to new application of compound traditional medicine preparation collateral activating and pain relieving capsules to treating diabetic peripheral neuropathy. By means of clinical curative effect observation on the collateral activating and pain relieving capsules for diabetic peripheral neuropathy, it is found that the collateral activating and pain relieving capsules have the effect of obviously relieving numbness, pain and other symptoms of a patient on diabetic peripheral neuropathy, no obvious adverse reaction is found during treatment, and therefore the effectiveness and safety of the collateral activating and pain relieving capsules for treating diabetic peripheral neuropathy are determined. According to new application of the compound traditional medicine preparation collateral activating and pain relieving capsules to treating diabetic peripheral neuropathy, new content is added to treatment of diabetic peripheral neuropathy.
Description
technical field [0001] The invention relates to the field of medicine, in particular to a new clinical application of a traditional Chinese medicine compound preparation Huoluo Xiaotong capsule. Background technique [0002] Diabetic neuropathy is one of the chronic complications of diabetes, including diabetic peripheral neuropathy and diabetic autonomic neuropathy. [0003] The incidence of diabetic peripheral neuropathy (DPN) ranges from 30% to 90%. The main clinical features are sensory and motor disturbances in the distal extremities, manifested as limb numbness, acute pain, muscle weakness and atrophy, and weakened or absent tendon reflexes. According to clinical manifestations, it can be divided into bilateral symmetrical polyneuropathy and unilateral asymmetric polyneuropathy. It was relatively reversible in the early stage, and developed into intractable and refractory nerve injury in the later stage. The pathogenesis is not yet fully understood, and it is genera...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/716A61K9/48A61P25/02A61P3/10
CPCA61K9/1652A61K36/17A61K36/232A61K36/254A61K36/324A61K36/328A61K36/537A61K36/71A61K36/714A61K36/716A61K2300/00
Inventor 王衡新邓俐丽宋志林
Owner HINYE PHARM CO LTD